SCHEMBL7549155

SCHEMBL7549155

COc1ccc(-c2cncc(-c3cn(CCN4CCCCC4)c4ccc(OC)cc34)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 5/20 0.56
FLT1 P17948 3/20 0.49
FLT4 P35916 3/20 0.49
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.47
RCE1 Q9Y256 1/20 0.47
HSD17B10 Q99714 1/20 0.46
ESR1 P03372 3/20 0.45
GSK3B P49841 3/20 0.44
QPCT Q16769 3/20 0.44
SIGMAR1 Q99720 1/20 0.42
HTR6 P50406 2/20 0.42
CNR2 P34972 2/20 0.42
CHRNB1 P11230 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7554276 0.94 KDR (0.52) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7551493 0.94 KDR (0.57) KDRFLT1FLT4ESR1GSK3B
SCHEMBL7550504 0.94 KDR (0.59) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7554609 0.92 KDR (0.52) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7547482 0.91 KDR (0.55) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7550594 0.91 KDR (0.56) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7555221 0.91 KDR (0.68) KDRFLT1FLT4GSK3BQPCT
SCHEMBL7987153 0.90 KDR (0.50) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7990663 0.89 KDR (0.73) KDRFLT1FLT4KDM4EALDH1A1
SCHEMBL7556233 0.89 KDR (0.54) KDRFLT1FLT4ESR1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed